Skip to main content Back to Top
Advertisement

1/14/2021

Lisinopril Tablets

Products Affected - Description

    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 5000 count, NDC 76282-0420-50
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 45 count, NDC 76282-0422-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 90 count, NDC 76282-0422-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 100 count, NDC 76282-0422-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 180 count, NDC 76282-0422-18
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 1000 count, NDC 76282-0422-10
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 1000 count, NDC 76282-0418-10
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 100 count, NDC 68180-0980-01
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 1000 count, NDC 68180-0980-03
    • Lisinopril oral tablet, Lupin, 2.5 mg, bottle, 100 count, NDC 68180-0512-01
    • Lisinopril oral tablet, Lupin, 2.5 mg, bottle, 500 count, NDC 68180-0512-02
    • Lisinopril oral tablet, Lupin, 20 mg, bottle, 100 count, NDC 68180-0981-01
    • Lisinopril oral tablet, Lupin, 30 mg, bottle, 100 count, NDC 68180-0982-01
    • Lisinopril oral tablet, Lupin, 30 mg, bottle, 500 count, NDC 68180-0982-02
    • Lisinopril oral tablet, Lupin, 40 mg, bottle, 100 count, NDC 68180-0517-01
    • Lisinopril oral tablet, Lupin, 40 mg, bottle, 1000 count, NDC 68180-0517-03
    • Lisinopril oral tablet, Lupin, 5 mg, bottle, 100 count, NDC 68180-0513-01
    • Lisinopril oral tablet, Lupin, 5 mg, bottle, 1000 count, NDC 68180-0513-03
    • Lisinopril oral tablet, Teva, 10 mg, bottle, 100 count, NDC 00591-0407-01
    • Lisinopril oral tablet, Teva, 10 mg, bottle, 1000 count, NDC 00591-0407-10
    • Lisinopril oral tablet, Teva, 2.5 mg, bottle, 100 count, NDC 00591-0405-01
    • Lisinopril oral tablet, Teva, 2.5 mg, bottle, 500 count, NDC 00591-0405-05
    • Lisinopril oral tablet, Teva, 20 mg, bottle, 100 count, NDC 00591-0408-01
    • Lisinopril oral tablet, Teva, 30 mg, bottle, 100 count, NDC 00591-0885-01
    • Lisinopril oral tablet, Teva, 40 mg, bottle, 500 count, NDC 00591-0409-05
    • Lisinopril oral tablet, Teva, 5 mg, bottle, 100 count, NDC 00591-0406-01
    • Lisinopril oral tablet, Teva, 5 mg, bottle, 1000 count, NDC 00591-0406-10

Reason for the Shortage

    • Exelan, Lupin, and Teva did not provide a reason for the shortage.
    • Major has lisinopril tablets available.

Available Products

    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 45 count, NDC 76282-0419-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 90 count, NDC 76282-0419-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 100 count, NDC 76282-0419-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 1000 count, NDC 76282-0419-10
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 2.5 mg, bottle, 100 count, NDC 76282-0417-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 2.5 mg, bottle, 500 count, NDC 76282-0417-05
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 45 count, NDC 76282-0420-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 90 count, NDC 76282-0420-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 100 count, NDC 76282-0420-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 180 count, NDC 76282-0420-18
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 1000 count, NDC 76282-0420-10
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 30 mg, bottle, 100 count, NDC 76282-0421-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 30 mg, bottle, 500 count, NDC 76282-0421-05
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 45 count, NDC 76282-0418-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 90 count, NDC 76282-0418-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 100 count, NDC 76282-0418-01
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 90 count, NDC 68180-0514-09
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 5000 count, NDC 68180-0980-30
    • Lisinopril oral tablet, Lupin, 2.5 mg, bottle, 90 count, NDC 68180-0512-09
    • Lisinopril oral tablet, Lupin, 20 mg, bottle, 90 count, NDC 68180-0515-09
    • Lisinopril oral tablet, Lupin, 20 mg, bottle, 1000 count, NDC 68180-0981-03
    • Lisinopril oral tablet, Lupin, 30 mg, bottle, 90 count, NDC 68180-0516-09
    • Lisinopril oral tablet, Lupin, 40 mg, bottle, 90 count, NDC 68180-0517-09
    • Lisinopril oral tablet, Lupin, 5 mg, bottle, 90 count, NDC 68180-0513-09
    • Lisinopril oral tablet, Major, 10 mg, unit-dose blister pack, 100 count, NDC 00904-6798-61
    • Lisinopril oral tablet, Major, 20 mg, unit-dose blister pack, 100 count, NDC 00904-6799-61
    • Lisinopril oral tablet, Major, 40 mg, unit-dose blister pack, 100 count, NDC 00904-6800-61
    • Lisinopril oral tablet, Major, 5 mg, unit-dose blister pack, 100 count, NDC 00904-6797-61
    • Lisinopril oral tablet, Teva, 20 mg, bottle, 1000 count, NDC 00591-0408-10
    • Lisinopril oral tablet, Teva, 40 mg, bottle, 100 count, NDC 00591-0409-01

Estimated Resupply Dates

    • Exelan has lisinopril 5 mg tablets in 1000 count and 20 mg tablets in 5000 count bottles on back order and the company cannot estimate a release date. The 40 mg tablet presentations are on back order and the company estimates release dates in late-January 2021.
    • Lupin has lisinopril 2.5 mg tablets in 100 count and 500 count bottles, 5 mg tablets in 100 count and 1000 count bottles, 10 mg tablets in 100 count and 1000 count bottles, 20 mg tablets in 100 count bottles, 30 mg tablets in 100 count and 500 count bottles, and 40 mg tablets in 100 count and 1000 count bottles on back order and the company cannot estimate a release date.
    • Teva has most lisinopril tablet presentations on back order and the company estimates release dates in mid-February 2021.

Updated

Updated January 14, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 30, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.